These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21479874)
1. Lymphatic differentiation in classic Kaposi's sarcoma: patterns of D2-40 immunoexpression in the course of tumor progression. Kandemir NO; Barut F; Gun BD; Keser SH; Karadayi N; Gun M; Ozdamar SO Pathol Oncol Res; 2011 Dec; 17(4):843-51. PubMed ID: 21479874 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Kahn HJ; Bailey D; Marks A Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918 [TBL] [Abstract][Full Text] [Related]
4. D2-40 negative pyogenic granuloma-like Kaposi's sarcoma: Diagnostic features and histogenetic hypothesis of an uncommon skin tumor in HIV-negative patients. Cabibi D; Giannone AG; Guarnotta C; Schillaci O; Franco V Pathol Res Pract; 2015 Jul; 211(7):528-32. PubMed ID: 25939289 [TBL] [Abstract][Full Text] [Related]
5. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development. Pyakurel P; Pak F; Mwakigonja AR; Kaaya E; Heiden T; Biberfeld P Int J Cancer; 2006 Sep; 119(6):1262-7. PubMed ID: 16615115 [TBL] [Abstract][Full Text] [Related]
6. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer. Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524 [TBL] [Abstract][Full Text] [Related]
7. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40. Dubina M; Goldenberg G J Am Acad Dermatol; 2009 Aug; 61(2):276-80. PubMed ID: 19615538 [TBL] [Abstract][Full Text] [Related]
8. Utility of immunohistochemical staining with FLI1, D2-40, CD31, and CD34 in the diagnosis of acquired immunodeficiency syndrome-related and non-acquired immunodeficiency syndrome-related Kaposi sarcoma. Rosado FG; Itani DM; Coffin CM; Cates JM Arch Pathol Lab Med; 2012 Mar; 136(3):301-4. PubMed ID: 22372906 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point. Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680 [TBL] [Abstract][Full Text] [Related]
10. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Fukunaga M Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of endothelial markers and HHV-8 staining in gastrointestinal Kaposi sarcoma and its difference in endoscopic tumor staging. Nagata N; Igari T; Shimbo T; Sekine K; Akiyama J; Hamada Y; Yazaki H; Ohmagari N; Teruya K; Oka S; Uemura N World J Gastroenterol; 2013 Jun; 19(23):3608-14. PubMed ID: 23801862 [TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma. Hodak E; Hammel I; Feinmesser M; Zelinger A; Maron L; Sulkes J; David M Am J Dermatopathol; 1999 Apr; 21(2):138-45. PubMed ID: 10218673 [TBL] [Abstract][Full Text] [Related]
14. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Galambos C; Nodit L Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202 [TBL] [Abstract][Full Text] [Related]
15. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer. Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803 [TBL] [Abstract][Full Text] [Related]
17. Angiomatous kaposi sarcoma: a variant that mimics hemangiomas. Yang SH; LeBoit PE Am J Dermatopathol; 2014 Mar; 36(3):229-37. PubMed ID: 24067801 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma. Bergman R; Ramon M; Kilim S; Lichtig C; Friedman-Birnbaum R Am J Dermatopathol; 1996 Aug; 18(4):367-70. PubMed ID: 8879300 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Evangelou E; Kyzas PA; Trikalinos TA Mod Pathol; 2005 Nov; 18(11):1490-7. PubMed ID: 15990898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]